News Boehringer raises hope of oral drug for diabetic eye disease Boehringer has started a phase 2 trial of an oral therapy that could help people with diabetic macular oedema avoid regular injections into the eye.
News First malaria drug for newborns and young infants cleared A new formulation of Novartis' antimalarial Coartem has become the first medicine to be approved for use in very young children.
News Medical groups sue RFK Jr over COVID-19 policies Medical groups have sued HHS Secretary Robert F Kennedy Jr for removing healthy children and pregnant women from COVID-19 shot recommendations.
News Samsung builds digital health credentials with Xealth buy Samsung has reached a deal to buy Xealth, a US company set up to help healthcare professionals prescribe digital health technologies.
News Apogee rises as long-acting eczema drug heads for phase 3 Apogee shares have spiked on data showing strong efficacy with its atopic dermatitis drug and the potential for dosing just two to four times a year.
News KalVista bags FDA approval for delayed oral HAE drug KalVista has brought the first oral, on-demand treatment for hereditary angioedema attacks to the US market.
News MSD takes a $400m bite of SciBrunch's KRAS drug MSD has signed a license agreement for a KRAS G12D inhibitor from China's SciBrunch, paying $400m upfront for the preclinical candidate.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.